Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kathleen, Tenner"'
Autor:
Saranya Chumsri, Zhuo Li, Daniel J. Serie, Nadine Norton, Afshin Mashadi-Hossein, Kathleen Tenner, Heather Ann Brauer, Sarah Warren, Patrick Danaher, Gerardo Colon-Otero, Ann H. Partridge, Lisa A. Carey, Florentine Hilbers, Veerle Van Dooren, Eileen Holmes, Serena Di Cosimo, Olena Werner, Jens Bodo Huober, Amylou C. Dueck, Christos Sotiriou, Cristina Saura, Alvaro Moreno-Aspitia, Keith L. Knutson, Edith A. Perez, E. Aubrey Thompson
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-8 (2022)
Abstract Trastuzumab acts in part through the adaptive immune system. Previous studies showed that enrichment of immune-related gene expression was associated with improved outcomes in HER2-positive (HER2+) breast cancer. However, the role of the imm
Externí odkaz:
https://doaj.org/article/c541e25cb1954a448e8d1d99ad81395d
Autor:
Edith A. Perez, Keith L. Knutson, Raphael Clynes, Karla V. Ballman, Kathleen Tenner, Mark Pegram, Rebecca M. Olson, Nadine Norton
Supplementary Table S1. Patient characteristics genotyped cohort vs non-genotyped cohort. Supplementary Table S2. Patient characteristics according to FCGR3A genotype. Supplementary Table S3. Patient characteristics according to FCGR2A genotype. Supp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::046041a0da5a33d146faaf892f6beda8
https://doi.org/10.1158/2326-6066.22536017.v1
https://doi.org/10.1158/2326-6066.22536017.v1
Autor:
Edith A. Perez, Keith L. Knutson, Raphael Clynes, Karla V. Ballman, Kathleen Tenner, Mark Pegram, Rebecca M. Olson, Nadine Norton
Patients with HER2+ breast cancer treated with trastuzumab and chemotherapy have superior survival compared with patients treated with chemotherapy alone. Polymorphisms within FCGR2A and FCGR3A are associated with binding affinity of natural killer c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0accaa84ccd6decc170a50ab298ae2e
https://doi.org/10.1158/2326-6066.c.6548018.v1
https://doi.org/10.1158/2326-6066.c.6548018.v1
Autor:
Edith A. Perez, Wilma L. Lingle, James N. Ingle, Lyndsay N. Harris, Julie Gralow, Leila A. Kutteh, Peter A. Kaufman, George W. Sledge, Silvana Martino, Nancy E. Davidson, Ann E. McCullough, Beiyun Chen, Darren Riehle, Robert B. Jenkins, Karla Ballman, Kathleen Tenner, Xochiquetzal J. Geiger, Monica M. Reinholz, Amylou C. Dueck
Supplementary Figure 2 - PDF file 9846K, Patient Flow Diagram for N9831 MYC IHC Analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d057d4aa327282e7f1f2233ba342551
https://doi.org/10.1158/1078-0432.22450161
https://doi.org/10.1158/1078-0432.22450161
Autor:
Edith A. Perez, Wilma L. Lingle, Philip J. Stella, Jake B. Allred, Betsy LaPlant, Vivek Roy, Alvaro Moreno-Aspitia, Donald W. Northfelt, Timothy J. Hobday, Amylou C. Dueck, David Hillman, Kathleen Tenner, Kathleen A. Kitzmann, Monica M. Reinholz
PDF file - 180KB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24d9f98691e6d83ac72904ddf03c5c28
https://doi.org/10.1158/1078-0432.22444238.v1
https://doi.org/10.1158/1078-0432.22444238.v1
Autor:
Edith A. Perez, Wilma L. Lingle, James N. Ingle, Lyndsay N. Harris, Julie Gralow, Leila A. Kutteh, Peter A. Kaufman, George W. Sledge, Silvana Martino, Nancy E. Davidson, Ann E. McCullough, Beiyun Chen, Darren Riehle, Robert B. Jenkins, Karla Ballman, Kathleen Tenner, Xochiquetzal J. Geiger, Monica M. Reinholz, Amylou C. Dueck
Purpose: This study investigated the association between tumor MYC protein expression and disease-free survival (DFS) of patients randomized to receive chemotherapy alone (Arm A) or chemotherapy with sequential (Arm B) or concurrent trastuzumab (Arm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ea18f7f7f6da36d320aea9d94901cb9
https://doi.org/10.1158/1078-0432.c.6521868.v1
https://doi.org/10.1158/1078-0432.c.6521868.v1
Autor:
Edith A. Perez, Ann E. McCullough, Xochiquetzal J. Geiger, Robert B. Jenkins, Darren Riehle, Karla Ballman, Kathleen Tenner, Amylou C. Dueck, Beiyun Chen, Monica M. Reinholz
Background: Preclinical evidence indicates that increased insulin-like growth factor receptor-1 (IGF1R) signaling interferes with the action of trastuzumab suggesting a possible mechanism of trastuzumab resistance. Thus, we evaluated IGF1R prevalence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::663385b8bc387a3f8b237cd78335ffd0
https://doi.org/10.1158/1078-0432.c.6524648.v1
https://doi.org/10.1158/1078-0432.c.6524648.v1
Autor:
Edith A. Perez, Ann E. McCullough, Xochiquetzal J. Geiger, Robert B. Jenkins, Darren Riehle, Karla Ballman, Kathleen Tenner, Amylou C. Dueck, Beiyun Chen, Monica M. Reinholz
Supplemental Table 1. Heterogeneity of Cores in Patients with Multiple Cores (N=961) Supplemental Table 2. Clinicopathological Characteristics of Cohort and Non-Cohort Patients. Supplemental Table 3. Patient/Disease Characteristics by {greater than o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c46f3f12e2c69afc7f525e572335dcc
https://doi.org/10.1158/1078-0432.22460945.v1
https://doi.org/10.1158/1078-0432.22460945.v1
Autor:
Edith A. Perez, Wilma L. Lingle, James N. Ingle, Lyndsay N. Harris, Julie Gralow, Leila A. Kutteh, Peter A. Kaufman, George W. Sledge, Silvana Martino, Nancy E. Davidson, Ann E. McCullough, Beiyun Chen, Darren Riehle, Robert B. Jenkins, Karla Ballman, Kathleen Tenner, Xochiquetzal J. Geiger, Monica M. Reinholz, Amylou C. Dueck
Supplementary Tables 1-5 - PDF file 91K, Supplementary Table 1. Patient Characteristics by IHC cMYC Cohort vs Non-Cohort; Supplementary Table 2. Correlation of MYC Nuclear Staining with HER2 FISH - Overall; Supplementary Table 3. Correlation of MYC N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23cc280426f802390d2d8ad55acec459
https://doi.org/10.1158/1078-0432.22450158.v1
https://doi.org/10.1158/1078-0432.22450158.v1
Autor:
Edith A. Perez, Wilma L. Lingle, James N. Ingle, Lyndsay N. Harris, Julie Gralow, Leila A. Kutteh, Peter A. Kaufman, George W. Sledge, Silvana Martino, Nancy E. Davidson, Ann E. McCullough, Beiyun Chen, Darren Riehle, Robert B. Jenkins, Karla Ballman, Kathleen Tenner, Xochiquetzal J. Geiger, Monica M. Reinholz, Amylou C. Dueck
Supplementary Figure 1 - PDF file 5863K, NCCTG N9831 Trial Incorporating Trastuzumab in Adjuvant Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a137a53a0d4955540dbd44e04e9e7b0
https://doi.org/10.1158/1078-0432.22450164
https://doi.org/10.1158/1078-0432.22450164